Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,264.12
-63.59 (-4.79%)
At close: Aug 4, 2026
EGX:AXPH Financials Overview
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 3,117 | 2,751 | 1,768 | 1,484 | 1,100 | 1,104 |
Revenue Growth | 24.95% | 55.56% | 19.12% | 34.94% | -0.38% | 7.75% |
Gross Profit Gross Profit Growth | 787.51 | 658.95 | 395.18 | 260.89 | 223.24 | 262.8 |
Operating Income Operating Income Growth | 644.31 | 504.7 | 267.49 | 154.92 | 134.54 | 154.11 |
Net Income Net Income Growth | 499 | 391.17 | 216.68 | 126.43 | 117.42 | 117 |
Earnings Per Share EPS Growth | 99.80 | 78.23 | 43.34 | 25.29 | 23.48 | 23.40 |
EPS Growth | 43.31% | 80.53% | 71.39% | 7.67% | 0.36% | -18.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 416.06 | 285.8 | 150.04 | 90.51 | 153.75 | 52.12 |
Total Debt Total Debt Growth | 6.35 | 4.08 | 0.81 | 12.03 | 9.11 | 1.77 |
Net Cash (Debt) Net Cash Growth | 409.71 | 281.72 | 149.22 | 78.48 | 144.63 | 50.35 |
Net Cash Growth | 141.21% | 88.79% | 90.14% | -45.74% | 187.27% | -68.29% |
Net Cash Per Share Net Cash Per Share Growth | 81.94 | 56.34 | 29.84 | 15.70 | 28.93 | 10.07 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 609.12 | 335.99 | 189.62 | 91.34 | 192.75 | 99.42 |
Capital Expenditures CapEx Growth | -66.12 | -29.72 | -62.22 | -84.25 | -31.85 | -119.99 |
Free Cash Flow Free Cash Flow Growth | 543 | 306.27 | 127.41 | 7.09 | 160.9 | -20.57 |
Free Cash Flow Growth | 211.88% | 140.39% | 1696.05% | -95.59% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 25.26% | 23.96% | 22.35% | 17.58% | 20.29% | 23.80% |
Operating Margin | 20.67% | 18.35% | 15.13% | 10.44% | 12.23% | 13.96% |
Pretax Margin | 20.59% | 18.50% | 15.95% | 11.11% | 13.05% | 13.73% |
Profit Margin | 16.01% | 14.22% | 12.26% | 8.52% | 10.67% | 10.60% |
FCF Margin | 17.42% | 11.13% | 7.21% | 0.48% | 14.63% | -1.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 62.950 | 62.950 | 30.000 | 13.000 | - | 10.000 |
Dividend Per Share Growth | 109.83% | 109.83% | 130.77% | - | - | -35.48% |
Dividend Yield | 4.98% | 15.19% | 16.89% | 12.11% | - | 11.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 12.62 | 5.70 | 4.86 | 5.47 | 4.51 | 5.77 |
Forward PE | - | 4.57 | 4.57 | 4.57 | 4.57 | 4.30 |
P/FCF Ratio | 11.60 | 7.28 | 8.27 | 97.40 | 3.29 | - |
PS Ratio | 2.02 | 0.81 | 0.60 | 0.47 | 0.48 | 0.61 |